在体心脏弥散张量成像早期识别肥厚型心肌病心肌微结构改变
这项前瞻性研究纳入35例肥厚型心肌病患者和15名健康志愿者,在3.0-T扫描仪上行心脏MRI(含电影、延迟钆增强、T1 mapping及心脏弥散张量成像),按美国心脏协会六节段分析。结果显示肥厚型心肌病组较对照组各向异性分数降低、舒张期第二特征向量角增大,且无肥厚或延迟钆增强的节段也已出现异常,提示心脏弥散张量成像可在常规影像发现异常之前识别心肌微结构改变。
要点
- 肥厚型心肌病组各向异性分数较对照组降低(0.33±0.05 vs 0.46±0.04),舒张期第二特征向量角增大(48.85°±7.13 vs 35.05°±5.06)。
- 无肥厚且无延迟钆增强的肥厚型心肌病节段,各向异性分数和舒张期第二特征向量角仍与对照组有差异。
- 各向异性分数和舒张期第二特征向量角识别肥厚型心肌病节段的AUC分别为0.81和0.79,高于原生T1的0.67。
核心结论
- 在体心脏弥散张量成像可在无肥厚或纤维化时识别肥厚型心肌病的心肌排列紊乱和微结构动力学异常,提示其对肥厚型心肌病组织定性的潜在价值。
研究设计与样本
- 前瞻性研究,2023年4月至8月纳入35例肥厚型心肌病患者和15名健康志愿者,使用3.0-T扫描仪行心脏MRI(电影、延迟钆增强、T1 mapping及心脏弥散张量成像),延迟钆增强仅用于肥厚型心肌病患者。
诊断标准与关键数值
- 各向异性分数识别肥厚型心肌病节段与正常节段的AUC为0.81(95%CI:0.76,0.86),舒张期第二特征向量角AUC为0.79(95%CI:0.74,0.84),原生T1 AUC为0.67(95%CI:0.61,0.72)。
临床应用与阅片要点
- 阅片时可关注心脏弥散张量成像参数:肥厚型心肌病节段各向异性分数降低、舒张期第二特征向量角增大,且这些改变可出现在无肥厚或延迟钆增强的节段。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Purpose To explore the diffusion characteristics of hypertrophic cardiomyopathy (HCM) using in vivo cardiac diffusion-tensor imaging (cDTI) and to determine whether cDTI could help identify abnormal myocardium beyond cardiac MRI findings of fibrosis and hypertrophy. Materials and Methods In this prospective study conducted from April to August 2023, participants with HCM and healthy volunteers were enrolled for cardiac MRI evaluation, including cine, late gadolinium enhancement (LGE), T1 mapping, and cDT imaging, using a 3.0-T scanner. LGE was performed only in participants with HCM. All cardiac MR images of the midventricular section were divided into six American Heart Association segments for segmental analysis. Repeated measure analysis of variance and Friedman test were used to compare cDTI parameters among different segments, and a linear mixed-effects model was fitted to account for within-participant clustering. Diagnostic performance of cDTI parameters in discriminating HCM segments from normal segments was assessed using receiver operating characteristic (ROC) analysis. Results Thirty-five participants with HCM (mean age, 46 years ± 13 [SD]; 19 [54%] male) and 15 healthy volunteers (mean age, 43 years ± 17; nine [60%] male) were included. Compared with controls, the HCM group showed significantly reduced fractional anisotropy (FA) (mean, 0.33 ± 0.05 vs 0.46 ± 0.04; P < .001) and increased diastolic second eigenvector angle (E2A) (mean, 48.85° ± 7.13 vs 35.05° ± 5.06; P < .001). In segmental analysis, FA and diastolic E2A of HCM segments with no hypertrophy or LGE also significantly differed from controls (estimated marginal mean, FA: 0.39 [95% CI: 0.38, 0.41] vs 0.45 [95% CI: 0.43, 0.47]; E2A: 46.03° [95% CI: 43.45, 48.62] vs 35.69° [95% CI: 31.69, 39.69]; both P < .001), with no evidence of a difference in native T1 values (estimated marginal mean, 1282.43 msec [95% CI: 1267.55, 1297.30] vs 1265.57 msec [95% CI: 1242.86, 1288.28]; P = .47). FA (area under the ROC curve [AUC], 0.81 [95% CI: 0.76, 0.86]) and diastolic E2A (AUC, 0.79 [95% CI: 0.74, 0.84]) showed higher performance than native T1 (AUC, 0.67 [95% CI: 0.61, 0.72]) in identifying HCM segments from normal segments (P < .001 and P = .007, respectively). Conclusion Myocardial disarray and abnormal microstructural dynamics of HCM can be identified by using in vivo cDTI even in the absence of hypertrophy or fibrosis, suggesting the potential value of cDTI in tissue characterization of HCM. Keywords: Cardiovascular MR Imaging, Hypertrophic Cardiomyopathy, Diffusion-Tensor Imaging, Myocardial Microstructure Supplemental material is available for this article. Published under a CC BY 4.0 license.
引用
- Dong Z, Tang Y, Sun P, et al. Early Identification of Myocardial Microstructural Alterations in Hypertrophic Cardiomyopathy with in Vivo Cardiac Diffusion-Tensor Imaging. Radiol Cardiothorac Imaging. 2025. PMID: 39745326. doi:10.1148/ryct.240009
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。